YAP Promotes Chemoresistance to 5-FU in Colorectal Cancer Through mTOR/GLUT3 Axis

作者：Qixuan Xu, Zhesi Jin, Zhen Yuan, Zhiyuan Yu, Jingwang Gao, Ruiyang Zhao, Hanghang Li, Huiguang Ren, Bo Cao, Bo Wei, Lin‐Hua Jiang · 发表于：Journal of Cancer · 年份：2024 · DOI：10.7150/jca.100179 · 被引用次数：10 · 研究领域：Hippo pathway signaling and YAP/TAZ

Background: Although chemoresistance constitutes a significant barrier to the effectiveness of chemotherapy in colorectal cancer (CRC), its precise mechanisms remain unclear.YAP functions as an oncogene in various malignancies.However, the relationship between YAP and chemoresistance in CRC needs clarification.Methods: The expression level of YAP in CRC tissues was assessed through immunohistochemistry (IHC), and the impact of YAP on CRC cell chemoresistance was evaluated using the Cell Counting Kit-8, EdU, and flow cytometry assays.Meanwhile, tumor proliferation was assessed in vivo by analyzing the expression of PCNA and Ki-67 in subcutaneous tumors via IHC.In addition, the TUNEL assay was employed to evaluate tumor apoptosis levels and western blot was utilized to detect the mTOR/GLUT3 pathway-related protein expression to provide insights into the underlying mechanism.Results: YAP was highly expressed in CRC tissues and correlated with patient prognosis and clinicopathological features.Bioinformatic analysis based on the TCGA database revealed that YAP was associated with DNA replication, glycolysis, and the mTOR pathway.Meanwhile, YAP could enhance chemoresistance and glycolysis in CRC cells both in vitro and in vivo.Additional mechanistic experiments unveiled that YAP promoted CRC cell chemoresistance via the mTOR/GLUT3 axis. Conclusion:This study validated the role of YAP as an oncogene in CRC, as it promoted chemoresistance through the mTOR/GLUT3 axis.These results su...